 | • レポートコード：QYR2104Z1632 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、133ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、新型コロナウイルス感染症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（生命維持、抗ウイルス薬、血漿療法、免疫療法、その他）、用途別市場規模（子供、成人）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・新型コロナウイルス感染症治療の市場動向 ・企業の競争状況、市場シェア ・新型コロナウイルス感染症治療の種類別市場規模（生命維持、抗ウイルス薬、血漿療法、免疫療法、その他） ・新型コロナウイルス感染症治療の用途別市場規模（子供、成人） ・新型コロナウイルス感染症治療の北米市場規模2016-2027（アメリカ、カナダ） ・新型コロナウイルス感染症治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・新型コロナウイルス感染症治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・新型コロナウイルス感染症治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・新型コロナウイルス感染症治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Cadila Healthcare、Johnson & Johnson、ImmunoPrecise、Novartis、AstraZeneca、Cipla、AbbVie、Bayer、Regeneron Pharmaceuticals、Ascletis Pharma、GlaxoSmithKline、Gilead Sciences、Pharmstandard、Fujifilm Holdings、Zhejiang Hisun Pharmaceutical Co. Ltd、Roche、Sanofi、Pfizer） ・結論 |
Most people who become ill with COVID-19 will be able to recover at home. No specific treatments for COVID-19 exist right now. But some of the same things you do to feel better if you have the flu — getting enough rest, staying well hydrated, and taking medications to relieve fever and aches and pains — also help with COVID-19.
In the meantime, scientists are working hard to develop effective treatments. Therapies that are under investigation include drugs that have been used to treat malaria and autoimmune diseases; antiviral drugs that were developed for other viruses, and antibodies from people who have recovered from COVID-19.
Market Analysis and Insights: Global Covid-19 Treatment Market
The global Covid-19 Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Covid-19 Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Covid-19 Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Covid-19 Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Covid-19 Treatment market.
Global Covid-19 Treatment Scope and Market Size
Covid-19 Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Covid-19 Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Life Support
Antiviral Medicine
Plasma Therapy
Immunotherapy
Others
Segment by Application
Children
Adult
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Cadila Healthcare
Johnson & Johnson
ImmunoPrecise
Novartis
AstraZeneca
Cipla
AbbVie
Bayer
Regeneron Pharmaceuticals
Novartis
AstraZeneca
Gilead Sciences
Pharmstandard
Fujifilm Holdings
Zhejiang Hisun Pharmaceutical Co. Ltd
Roche
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Covid-19 Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Life Support
1.2.3 Antiviral Medicine
1.2.4 Plasma Therapy
1.2.5 Immunotherapy
1.2.6 Others
1.3 Market by Application
1.3.1 Global Covid-19 Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Children
1.3.3 Adult
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Covid-19 Treatment Market Perspective (2016-2027)
2.2 Covid-19 Treatment Growth Trends by Regions
2.2.1 Covid-19 Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Covid-19 Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Covid-19 Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Covid-19 Treatment Industry Dynamic
2.3.1 Covid-19 Treatment Market Trends
2.3.2 Covid-19 Treatment Market Drivers
2.3.3 Covid-19 Treatment Market Challenges
2.3.4 Covid-19 Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Covid-19 Treatment Players by Revenue
3.1.1 Global Top Covid-19 Treatment Players by Revenue (2016-2021)
3.1.2 Global Covid-19 Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Covid-19 Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Covid-19 Treatment Revenue
3.4 Global Covid-19 Treatment Market Concentration Ratio
3.4.1 Global Covid-19 Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Covid-19 Treatment Revenue in 2020
3.5 Covid-19 Treatment Key Players Head office and Area Served
3.6 Key Players Covid-19 Treatment Product Solution and Service
3.7 Date of Enter into Covid-19 Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Covid-19 Treatment Breakdown Data by Type
4.1 Global Covid-19 Treatment Historic Market Size by Type (2016-2021)
4.2 Global Covid-19 Treatment Forecasted Market Size by Type (2022-2027)
5 Covid-19 Treatment Breakdown Data by Application
5.1 Global Covid-19 Treatment Historic Market Size by Application (2016-2021)
5.2 Global Covid-19 Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Covid-19 Treatment Market Size (2016-2027)
6.2 North America Covid-19 Treatment Market Size by Type
6.2.1 North America Covid-19 Treatment Market Size by Type (2016-2021)
6.2.2 North America Covid-19 Treatment Market Size by Type (2022-2027)
6.2.3 North America Covid-19 Treatment Market Size by Type (2016-2027)
6.3 North America Covid-19 Treatment Market Size by Application
6.3.1 North America Covid-19 Treatment Market Size by Application (2016-2021)
6.3.2 North America Covid-19 Treatment Market Size by Application (2022-2027)
6.3.3 North America Covid-19 Treatment Market Size by Application (2016-2027)
6.4 North America Covid-19 Treatment Market Size by Country
6.4.1 North America Covid-19 Treatment Market Size by Country (2016-2021)
6.4.2 North America Covid-19 Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Covid-19 Treatment Market Size (2016-2027)
7.2 Europe Covid-19 Treatment Market Size by Type
7.2.1 Europe Covid-19 Treatment Market Size by Type (2016-2021)
7.2.2 Europe Covid-19 Treatment Market Size by Type (2022-2027)
7.2.3 Europe Covid-19 Treatment Market Size by Type (2016-2027)
7.3 Europe Covid-19 Treatment Market Size by Application
7.3.1 Europe Covid-19 Treatment Market Size by Application (2016-2021)
7.3.2 Europe Covid-19 Treatment Market Size by Application (2022-2027)
7.3.3 Europe Covid-19 Treatment Market Size by Application (2016-2027)
7.4 Europe Covid-19 Treatment Market Size by Country
7.4.1 Europe Covid-19 Treatment Market Size by Country (2016-2021)
7.4.2 Europe Covid-19 Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Covid-19 Treatment Market Size (2016-2027)
8.2 Asia-Pacific Covid-19 Treatment Market Size by Type
8.2.1 Asia-Pacific Covid-19 Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Covid-19 Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Covid-19 Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Covid-19 Treatment Market Size by Application
8.3.1 Asia-Pacific Covid-19 Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Covid-19 Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Covid-19 Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Covid-19 Treatment Market Size by Region
8.4.1 Asia-Pacific Covid-19 Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Covid-19 Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Covid-19 Treatment Market Size (2016-2027)
9.2 Latin America Covid-19 Treatment Market Size by Type
9.2.1 Latin America Covid-19 Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Covid-19 Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Covid-19 Treatment Market Size by Type (2016-2027)
9.3 Latin America Covid-19 Treatment Market Size by Application
9.3.1 Latin America Covid-19 Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Covid-19 Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Covid-19 Treatment Market Size by Application (2016-2027)
9.4 Latin America Covid-19 Treatment Market Size by Country
9.4.1 Latin America Covid-19 Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Covid-19 Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Covid-19 Treatment Market Size (2016-2027)
10.2 Middle East & Africa Covid-19 Treatment Market Size by Type
10.2.1 Middle East & Africa Covid-19 Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Covid-19 Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Covid-19 Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Covid-19 Treatment Market Size by Application
10.3.1 Middle East & Africa Covid-19 Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Covid-19 Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Covid-19 Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Covid-19 Treatment Market Size by Country
10.4.1 Middle East & Africa Covid-19 Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Covid-19 Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Cadila Healthcare
11.1.1 Cadila Healthcare Company Details
11.1.2 Cadila Healthcare Business Overview
11.1.3 Cadila Healthcare Covid-19 Treatment Introduction
11.1.4 Cadila Healthcare Revenue in Covid-19 Treatment Business (2016-2021)
11.1.5 Cadila Healthcare Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Details
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Covid-19 Treatment Introduction
11.2.4 Johnson & Johnson Revenue in Covid-19 Treatment Business (2016-2021)
11.2.5 Johnson & Johnson Recent Development
11.3 ImmunoPrecise
11.3.1 ImmunoPrecise Company Details
11.3.2 ImmunoPrecise Business Overview
11.3.3 ImmunoPrecise Covid-19 Treatment Introduction
11.3.4 ImmunoPrecise Revenue in Covid-19 Treatment Business (2016-2021)
11.3.5 ImmunoPrecise Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Covid-19 Treatment Introduction
11.4.4 Novartis Revenue in Covid-19 Treatment Business (2016-2021)
11.4.5 Novartis Recent Development
11.5 AstraZeneca
11.5.1 AstraZeneca Company Details
11.5.2 AstraZeneca Business Overview
11.5.3 AstraZeneca Covid-19 Treatment Introduction
11.5.4 AstraZeneca Revenue in Covid-19 Treatment Business (2016-2021)
11.5.5 AstraZeneca Recent Development
11.6 Cipla
11.6.1 Cipla Company Details
11.6.2 Cipla Business Overview
11.6.3 Cipla Covid-19 Treatment Introduction
11.6.4 Cipla Revenue in Covid-19 Treatment Business (2016-2021)
11.6.5 Cipla Recent Development
11.7 AbbVie
11.7.1 AbbVie Company Details
11.7.2 AbbVie Business Overview
11.7.3 AbbVie Covid-19 Treatment Introduction
11.7.4 AbbVie Revenue in Covid-19 Treatment Business (2016-2021)
11.7.5 AbbVie Recent Development
11.8 Bayer
11.8.1 Bayer Company Details
11.8.2 Bayer Business Overview
11.8.3 Bayer Covid-19 Treatment Introduction
11.8.4 Bayer Revenue in Covid-19 Treatment Business (2016-2021)
11.8.5 Bayer Recent Development
11.9 Regeneron Pharmaceuticals
11.9.1 Regeneron Pharmaceuticals Company Details
11.9.2 Regeneron Pharmaceuticals Business Overview
11.9.3 Regeneron Pharmaceuticals Covid-19 Treatment Introduction
11.9.4 Regeneron Pharmaceuticals Revenue in Covid-19 Treatment Business (2016-2021)
11.9.5 Regeneron Pharmaceuticals Recent Development
11.10 Ascletis Pharma
11.10.1 Ascletis Pharma Company Details
11.10.2 Ascletis Pharma Business Overview
11.10.3 Ascletis Pharma Covid-19 Treatment Introduction
11.10.4 Ascletis Pharma Revenue in Covid-19 Treatment Business (2016-2021)
11.10.5 Ascletis Pharma Recent Development
11.11 GlaxoSmithKline
11.11.1 GlaxoSmithKline Company Details
11.11.2 GlaxoSmithKline Business Overview
11.11.3 GlaxoSmithKline Covid-19 Treatment Introduction
11.11.4 GlaxoSmithKline Revenue in Covid-19 Treatment Business (2016-2021)
11.11.5 GlaxoSmithKline Recent Development
11.12 Gilead Sciences
11.12.1 Gilead Sciences Company Details
11.12.2 Gilead Sciences Business Overview
11.12.3 Gilead Sciences Covid-19 Treatment Introduction
11.12.4 Gilead Sciences Revenue in Covid-19 Treatment Business (2016-2021)
11.12.5 Gilead Sciences Recent Development
11.13 Pharmstandard
11.13.1 Pharmstandard Company Details
11.13.2 Pharmstandard Business Overview
11.13.3 Pharmstandard Covid-19 Treatment Introduction
11.13.4 Pharmstandard Revenue in Covid-19 Treatment Business (2016-2021)
11.13.5 Pharmstandard Recent Development
11.14 Fujifilm Holdings
11.14.1 Fujifilm Holdings Company Details
11.14.2 Fujifilm Holdings Business Overview
11.14.3 Fujifilm Holdings Covid-19 Treatment Introduction
11.14.4 Fujifilm Holdings Revenue in Covid-19 Treatment Business (2016-2021)
11.14.5 Fujifilm Holdings Recent Development
11.15 Zhejiang Hisun Pharmaceutical Co. Ltd
11.15.1 Zhejiang Hisun Pharmaceutical Co. Ltd Company Details
11.15.2 Zhejiang Hisun Pharmaceutical Co. Ltd Business Overview
11.15.3 Zhejiang Hisun Pharmaceutical Co. Ltd Covid-19 Treatment Introduction
11.15.4 Zhejiang Hisun Pharmaceutical Co. Ltd Revenue in Covid-19 Treatment Business (2016-2021)
11.15.5 Zhejiang Hisun Pharmaceutical Co. Ltd Recent Development
11.16 Roche
11.16.1 Roche Company Details
11.16.2 Roche Business Overview
11.16.3 Roche Covid-19 Treatment Introduction
11.16.4 Roche Revenue in Covid-19 Treatment Business (2016-2021)
11.16.5 Roche Recent Development
11.17 Sanofi
11.17.1 Sanofi Company Details
11.17.2 Sanofi Business Overview
11.17.3 Sanofi Covid-19 Treatment Introduction
11.17.4 Sanofi Revenue in Covid-19 Treatment Business (2016-2021)
11.17.5 Sanofi Recent Development
11.18 Pfizer
11.18.1 Pfizer Company Details
11.18.2 Pfizer Business Overview
11.18.3 Pfizer Covid-19 Treatment Introduction
11.18.4 Pfizer Revenue in Covid-19 Treatment Business (2016-2021)
11.18.5 Pfizer Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Covid-19 Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Life Support
Table 3. Key Players of Antiviral Medicine
Table 4. Key Players of Plasma Therapy
Table 5. Key Players of Immunotherapy
Table 6. Key Players of Others
Table 7. Global Covid-19 Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Covid-19 Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Covid-19 Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Covid-19 Treatment Market Share by Regions (2016-2021)
Table 11. Global Covid-19 Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Covid-19 Treatment Market Share by Regions (2022-2027)
Table 13. Covid-19 Treatment Market Trends
Table 14. Covid-19 Treatment Market Drivers
Table 15. Covid-19 Treatment Market Challenges
Table 16. Covid-19 Treatment Market Restraints
Table 17. Global Covid-19 Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Covid-19 Treatment Market Share by Players (2016-2021)
Table 19. Global Top Covid-19 Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Covid-19 Treatment as of 2020)
Table 20. Ranking of Global Top Covid-19 Treatment Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Covid-19 Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Covid-19 Treatment Product Solution and Service
Table 24. Date of Enter into Covid-19 Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Covid-19 Treatment Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Covid-19 Treatment Revenue Market Share by Type (2016-2021)
Table 28. Global Covid-19 Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Covid-19 Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Covid-19 Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Covid-19 Treatment Revenue Market Share by Application (2016-2021)
Table 32. Global Covid-19 Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Covid-19 Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Covid-19 Treatment Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Covid-19 Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Covid-19 Treatment Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Covid-19 Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Covid-19 Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Covid-19 Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Covid-19 Treatment Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Covid-19 Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Covid-19 Treatment Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Covid-19 Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Covid-19 Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Covid-19 Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Covid-19 Treatment Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Covid-19 Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Covid-19 Treatment Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Covid-19 Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Covid-19 Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Covid-19 Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Covid-19 Treatment Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Covid-19 Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Covid-19 Treatment Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Covid-19 Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Covid-19 Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Covid-19 Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Covid-19 Treatment Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Covid-19 Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Covid-19 Treatment Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Covid-19 Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Covid-19 Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Covid-19 Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 64. Cadila Healthcare Company Details
Table 65. Cadila Healthcare Business Overview
Table 66. Cadila Healthcare Covid-19 Treatment Product
Table 67. Cadila Healthcare Revenue in Covid-19 Treatment Business (2016-2021) & (US$ Million)
Table 68. Cadila Healthcare Recent Development
Table 69. Johnson & Johnson Company Details
Table 70. Johnson & Johnson Business Overview
Table 71. Johnson & Johnson Covid-19 Treatment Product
Table 72. Johnson & Johnson Revenue in Covid-19 Treatment Business (2016-2021) & (US$ Million)
Table 73. Johnson & Johnson Recent Development
Table 74. ImmunoPrecise Company Details
Table 75. ImmunoPrecise Business Overview
Table 76. ImmunoPrecise Covid-19 Treatment Product
Table 77. ImmunoPrecise Revenue in Covid-19 Treatment Business (2016-2021) & (US$ Million)
Table 78. ImmunoPrecise Recent Development
Table 79. Novartis Company Details
Table 80. Novartis Business Overview
Table 81. Novartis Covid-19 Treatment Product
Table 82. Novartis Revenue in Covid-19 Treatment Business (2016-2021) & (US$ Million)
Table 83. Novartis Recent Development
Table 84. AstraZeneca Company Details
Table 85. AstraZeneca Business Overview
Table 86. AstraZeneca Covid-19 Treatment Product
Table 87. AstraZeneca Revenue in Covid-19 Treatment Business (2016-2021) & (US$ Million)
Table 88. AstraZeneca Recent Development
Table 89. Cipla Company Details
Table 90. Cipla Business Overview
Table 91. Cipla Covid-19 Treatment Product
Table 92. Cipla Revenue in Covid-19 Treatment Business (2016-2021) & (US$ Million)
Table 93. Cipla Recent Development
Table 94. AbbVie Company Details
Table 95. AbbVie Business Overview
Table 96. AbbVie Covid-19 Treatment Product
Table 97. AbbVie Revenue in Covid-19 Treatment Business (2016-2021) & (US$ Million)
Table 98. AbbVie Recent Development
Table 99. Bayer Company Details
Table 100. Bayer Business Overview
Table 101. Bayer Revenue in Covid-19 Treatment Business (2016-2021) & (US$ Million)
Table 102. Bayer Recent Development
Table 103. Regeneron Pharmaceuticals Company Details
Table 104. Regeneron Pharmaceuticals Business Overview
Table 105. Regeneron Pharmaceuticals Covid-19 Treatment Product
Table 106. Regeneron Pharmaceuticals Revenue in Covid-19 Treatment Business (2016-2021) & (US$ Million)
Table 107. Regeneron Pharmaceuticals Recent Development
Table 108. Ascletis Pharma Company Details
Table 109. Ascletis Pharma Business Overview
Table 110. Ascletis Pharma Covid-19 Treatment Product
Table 111. Ascletis Pharma Revenue in Covid-19 Treatment Business (2016-2021) & (US$ Million)
Table 112. Ascletis Pharma Recent Development
Table 113. GlaxoSmithKline Company Details
Table 114. GlaxoSmithKline Business Overview
Table 115. GlaxoSmithKline Covid-19 Treatment Product
Table 116. GlaxoSmithKline Revenue in Covid-19 Treatment Business (2016-2021) & (US$ Million)
Table 117. GlaxoSmithKline Recent Development
Table 118. Gilead Sciences Company Details
Table 119. Gilead Sciences Business Overview
Table 120. Gilead Sciences Covid-19 Treatment Product
Table 121. Gilead Sciences Revenue in Covid-19 Treatment Business (2016-2021) & (US$ Million)
Table 122. Gilead Sciences Recent Development
Table 123. Pharmstandard Company Details
Table 124. Pharmstandard Business Overview
Table 125. Pharmstandard Covid-19 Treatment Product
Table 126. Pharmstandard Revenue in Covid-19 Treatment Business (2016-2021) & (US$ Million)
Table 127. Pharmstandard Recent Development
Table 128. Fujifilm Holdings Company Details
Table 129. Fujifilm Holdings Business Overview
Table 130. Fujifilm Holdings Covid-19 Treatment Product
Table 131. Fujifilm Holdings Revenue in Covid-19 Treatment Business (2016-2021) & (US$ Million)
Table 132. Fujifilm Holdings Recent Development
Table 133. Zhejiang Hisun Pharmaceutical Co. Ltd Company Details
Table 134. Zhejiang Hisun Pharmaceutical Co. Ltd Business Overview
Table 135. Zhejiang Hisun Pharmaceutical Co. Ltd Covid-19 Treatment Product
Table 136. Zhejiang Hisun Pharmaceutical Co. Ltd Revenue in Covid-19 Treatment Business (2016-2021) & (US$ Million)
Table 137. Zhejiang Hisun Pharmaceutical Co. Ltd Recent Development
Table 138. Roche Company Details
Table 139. Roche Business Overview
Table 140. Roche Covid-19 Treatment Product
Table 141. Roche Revenue in Covid-19 Treatment Business (2016-2021) & (US$ Million)
Table 142. Roche Recent Development
Table 143. Sanofi Company Details
Table 144. Sanofi Business Overview
Table 145. Sanofi Covid-19 Treatment Product
Table 146. Sanofi Revenue in Covid-19 Treatment Business (2016-2021) & (US$ Million)
Table 147. Sanofi Recent Development
Table 148. Pfizer Company Details
Table 149. Pfizer Business Overview
Table 150. Pfizer Covid-19 Treatment Product
Table 151. Pfizer Revenue in Covid-19 Treatment Business (2016-2021) & (US$ Million)
Table 152. Pfizer Recent Development
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Covid-19 Treatment Market Share by Type: 2020 VS 2027
Figure 2. Life Support Features
Figure 3. Antiviral Medicine Features
Figure 4. Plasma Therapy Features
Figure 5. Immunotherapy Features
Figure 6. Others Features
Figure 7. Global Covid-19 Treatment Market Share by Application: 2020 VS 2027
Figure 8. Children Case Studies
Figure 9. Adult Case Studies
Figure 10. Covid-19 Treatment Report Years Considered
Figure 11. Global Covid-19 Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Covid-19 Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Covid-19 Treatment Market Share by Regions: 2020 VS 2027
Figure 14. Global Covid-19 Treatment Market Share by Regions (2022-2027)
Figure 15. Global Covid-19 Treatment Market Share by Players in 2020
Figure 16. Global Top Covid-19 Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Covid-19 Treatment as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Covid-19 Treatment Revenue in 2020
Figure 18. Global Covid-19 Treatment Revenue Market Share by Type (2016-2021)
Figure 19. Global Covid-19 Treatment Revenue Market Share by Type (2022-2027)
Figure 20. North America Covid-19 Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Covid-19 Treatment Market Share by Type (2016-2027)
Figure 22. North America Covid-19 Treatment Market Share by Application (2016-2027)
Figure 23. North America Covid-19 Treatment Market Share by Country (2016-2027)
Figure 24. United States Covid-19 Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Covid-19 Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Covid-19 Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Covid-19 Treatment Market Share by Type (2016-2027)
Figure 28. Europe Covid-19 Treatment Market Share by Application (2016-2027)
Figure 29. Europe Covid-19 Treatment Market Share by Country (2016-2027)
Figure 30. Germany Covid-19 Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Covid-19 Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Covid-19 Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Covid-19 Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Covid-19 Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Covid-19 Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Covid-19 Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Covid-19 Treatment Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Covid-19 Treatment Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Covid-19 Treatment Market Share by Region (2016-2027)
Figure 40. China Covid-19 Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Covid-19 Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Covid-19 Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Covid-19 Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Covid-19 Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Covid-19 Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Covid-19 Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Covid-19 Treatment Market Share by Type (2016-2027)
Figure 48. Latin America Covid-19 Treatment Market Share by Application (2016-2027)
Figure 49. Latin America Covid-19 Treatment Market Share by Country (2016-2027)
Figure 50. Mexico Covid-19 Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Covid-19 Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Covid-19 Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Covid-19 Treatment Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Covid-19 Treatment Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Covid-19 Treatment Market Share by Country (2016-2027)
Figure 56. Turkey Covid-19 Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Covid-19 Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Covid-19 Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Cadila Healthcare Revenue Growth Rate in Covid-19 Treatment Business (2016-2021)
Figure 60. Johnson & Johnson Revenue Growth Rate in Covid-19 Treatment Business (2016-2021)
Figure 61. ImmunoPrecise Revenue Growth Rate in Covid-19 Treatment Business (2016-2021)
Figure 62. Novartis Revenue Growth Rate in Covid-19 Treatment Business (2016-2021)
Figure 63. AstraZeneca Revenue Growth Rate in Covid-19 Treatment Business (2016-2021)
Figure 64. Cipla Revenue Growth Rate in Covid-19 Treatment Business (2016-2021)
Figure 65. AbbVie Revenue Growth Rate in Covid-19 Treatment Business (2016-2021)
Figure 66. Bayer Revenue Growth Rate in Covid-19 Treatment Business (2016-2021)
Figure 67. Regeneron Pharmaceuticals Revenue Growth Rate in Covid-19 Treatment Business (2016-2021)
Figure 68. Ascletis Pharma Revenue Growth Rate in Covid-19 Treatment Business (2016-2021)
Figure 69. GlaxoSmithKline Revenue Growth Rate in Covid-19 Treatment Business (2016-2021)
Figure 70. Gilead Sciences Revenue Growth Rate in Covid-19 Treatment Business (2016-2021)
Figure 71. Pharmstandard Revenue Growth Rate in Covid-19 Treatment Business (2016-2021)
Figure 72. Fujifilm Holdings Revenue Growth Rate in Covid-19 Treatment Business (2016-2021)
Figure 73. Zhejiang Hisun Pharmaceutical Co. Ltd Revenue Growth Rate in Covid-19 Treatment Business (2016-2021)
Figure 74. Roche Revenue Growth Rate in Covid-19 Treatment Business (2016-2021)
Figure 75. Sanofi Revenue Growth Rate in Covid-19 Treatment Business (2016-2021)
Figure 76. Pfizer Revenue Growth Rate in Covid-19 Treatment Business (2016-2021)
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed
世界の新型コロナウイルス感染症治療市場規模・現状・予測（2021年-2027年） In 2021, the global Covid-19 Therapeutic market size will be US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027. This report focuses on the global Covid-19 Therapeutic status, future forecast, growth opportunity, key market, and key play…- 世界の新型コロナウイルス感染症治療市場規模・現状・予測（2021年-2027年） In 2021, the global Covid-19 Therapeutic market size will be US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027. This report focuses on the global Covid-19 Therapeutic status, future forecast, growth opportunity, key market, and key play…
- 世界の新型コロナウイルス感染症用臨床治療市場規模・現状・予測（2021年-2027年） In 2021, the global Clinical Treatment for Covid-19 market size will be US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027. This report focuses on the global Clinical Treatment for Covid-19 status, future forecast, growth opportunity, ke…
- 世界の新型コロナウイルス感染症用保険市場規模・現状・予測（2021年-2027年） In view of the enterprise to return to work and production and Covid-19.Some area in China, including Ningbo city, Hainan province, putian city, fujian province, by boosting set up Enterprise Prevention Covid-19 Insurance or Return to Work after Isolation and other innovation of insurance products.T…
- 世界の新型コロナウイルス感染症ワクチン・治療薬市場規模・現状・予測（2021年-2027年） In 2020, the global COVID-19 Vaccines & Therapeutics market size will be US$ XX million and it is expected to reach US$ XX million by the end of 2026, with a CAGR of XX% during 2021-2026. This report focuses on the global COVID-19 Vaccines & Therapeutics status, future forecast, growth opportunity, …